Evaluation of risk factors associated with the post-COVID-19

Authors

DOI:

https://doi.org/10.5433/1679-0367.2024v45n2p183

Keywords:

COVID-19, Viral genome, Epidemiological monitoring, Post-Acute COVID-19 syndrome

Abstract

Este estudo tem como objetivo avaliar os fatores de risco associados às condições pós-COVID-19 em moradores de João Pessoa, Paraíba, que foram infectados por variantes de preocupação (VOC) do SARS-CoV-2. Um estudo de coorte retrospectivo foi conduzido usando dados secundários de sistemas de informação de saúde e autorrelato online de manifestações pós-COVID-19 por pacientes. Identificamos 131 casos diagnosticados com VOC que concordaram em participar do estudo. Destes, 35,9% preencheram os critérios para condições pós-COVID-19. Os fatores de risco associados incluíram falta de ar/dessaturação, comorbidades preexistentes e infecção pela variante Gamma. Os dados mostram que receber pelo menos uma dose de uma vacina contra COVID-19 protege contra os sintomas pós-COVID, destacando a importância de manter os protocolos de vacinação contra COVID-19.

Downloads

Download data is not yet available.

Author Biographies

Martha Maria de Albuquerque Belo, Federal University of Paraíba

Master's degree in Public Health from the Universidade Federal da Paraíba (UFPB), João Pessoa, Paraíba, Brazil. Biomedical scientist at the Paraíba State Health Department (SES-PB), Health Surveillance Management, João Pessoa, Paraíba.

Danielle Carmem Porto Lucena , University of São Paulo

PhD student in Epidemiology at the Universidade de São Paulo (USP), São Paulo, São Paulo, Brazil. Nurse at the Paraíba State Health Department (SES-PB), Health Surveillance Management, João Pessoa, Paraíba

Marília Lourencio dos Santos, Federal University of Paraíba

Master's student in Gerontology at the Universidade Federal da Paraíba (UFPB), João Pessoa, Paraíba

Rafaela Jeane Pereira Cunha, Secretaria Municipal de Saúde de João Pessoa - SMS

Master's degree in Gerontology from the Universidade Federal da Paraíba (UFPB), João Pessoa, Paraíba, Brazil. Epidemiological Surveillance Technician at the Municipal Health Department of João Pessoa (SMS), Health Care Directorate, João Pessoa, Paraíba.

Gabrielle Haque Fernandes Pereira, Federal University of Paraíba

Undergraduate in Pharmacy at the Universidade Federal da Paraíba (UFPB), João Pessoa, Paraíba

Gabriel Rodrigues Martins de Freitas, Federal University of Paraíba

PhD in Pharmaceutical Sciences from the Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil. Professor at the Department of Pharmaceutical Sciences of the Universidade Federal da Paraíba (UFPB), João Pessoa, Paraíba.

References

Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263-4. doi: 10.1016/S0140-6736(22)00941-2.

Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, et al. Trajectory of long covid symptoms after covid-19 vaccination: community-based cohort study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.

Campos KR, Sacchi CT, Abbud A, Caterino-de-Araujo A. SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil. Rev Panam Salud Publica. 2021;45:e126. doi: 10.26633/RPSP.2021.126.

Centers of Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19): symptoms of Coronavirus [Internet]. Geórgia: CDC; 2020 [cited 2022 Dec 16]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.

Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.

Fernández-de-Las-Peñas C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, et al. Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature. Viruses. 2022;14(12):2629. doi: 10.3390/v14122629.

Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alz Res Therapy. 2020]. doi: 10.1186/s13195-020-00640-3.

Hernández-Aceituno A, García-Hernández A, Larumbe-Zabala, E. COVID-19 long-term sequelae: Omicron versus Alpha and Delta variants. Infect. Dis. Now. 2023];53:104688. doi: 10.1016/j.idnow.2023.104688.

Hoffman, JP. Regression models for categorical, count, and related variables: an applied approach. Oakland: University Of California Press; 2016. doi:10.1525/9780520965492.

Hugon J, Msika EF, Queneau M, Farid K, Paquet C. Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J Neurol. 2022. doi: 10.1007/s00415-021-10655-x.

Instituto Brasileiro de Geografia e Estatística. Censo 2010 [Internet]. Rio de Janeiro: IBGE; 2022 [citado 2022 ago 22]. Disponível em: https://cidades.ibge.gov.br/brasil/pb/joao-pessoa/panorama.

Lippi G, Nocini R, Henry BM. Analysis of online search trends suggests that SARS-CoV-2 Omicron (B.1.1.529) variant causes different symptoms. J Infect. 2022;84(5):e76-e. doi: 10.1016/j.jinf.2022.02.011.

Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Guia de Vigilância Epidemiológica: emergência de saúde pública de importância nacional pela doença pelo coronavírus 2019 - COVID-19 [Internet]. Brasília: Ministério da Saúde; 2022 [citado 2022 set 11]. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/coronavirus/guia-de-vigilancia-epidemiologica-covid-19_2021.pdf/view.

Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Vigilância Genômica do vírus SARS-CoV-2 no âmbito da SVS/MS [Internet]. Brasília: Ministério da Saúde; 2021 [citado 2022 set 10]. Disponível em: https://www.gov.br/saude/pt-br/coronavirus/publicacoes-tecnicas/guias-e-planos/vigilancia-genomica-do-virus-sars-cov-2.

Miranda DAP, Gomes SVC, Filgueiras PS, Corsini CA, Almeida NBF, Silva RA, et al. Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil. Trans R Soc Trop Med Hyg. 2022;116:1007-14. doi: 10.1093/trstmh/trac030.

Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27, 601-15. doi: 10.1038/s41591-021-01283-z.

Paraíba. Secretaria de Estado da Saúde. Confirmação da circulação comunitária da variante Delta (B.1.617.2) na Paraíba [Internet]. João Pessoa: Secretaria de Estado; 2021 [citado 2022 set 10]. (Nota Informativa nº 06). Disponível em: https://paraiba.pb.gov.br/diretas/saude/coronavirus/profissionais-de-saude/boletins-e-notas-tecnicas.

Penetra SLS, Silva MFB, Resende P, Pina-Costa A, Santos HFP, Guaraldo L, et al. Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil. Int J Infect Dis. 2022;114:58-61. doi: 10.1016/j.ijid.2021.10.048.

Potus F, Mai V, Lebret M, Malenfant S, Breton-Gagnon E, Lajoie AC, et al. Novel insights on the pulmonary vascular consequences of COVID-19 Am J Physiol Lung Cell Mol Physiol. 2020;319:L277-L88. doi: 10.1152/ajplung.00195.2020.

Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffman J, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1265-73. doi: 10.1001/jamacardio.2020.3557.

Rogers JP, Chesney E, Oliver D, Pollak TA, Mc Guire A, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611-27. doi: 10.1016/S2215-0366(20)30203-0.

Spinicci M, Graziani L, Tilli M, Nkurunziza J, Vellere I, Borchi B, et al. Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes. Viruses. 2022;14(11):2367. doi: 10.3390/v14112367.

Strain WD, Sherwood O, Banerjee A, Van der Togt V, Hishmeh L, Rossman J. The impact of COVID Vaccination on Symptoms of Long COVID: An International Survey of People with Lived Experience of Long COVID. Vaccines. 2022;10:652. doi: 10.3390/vaccines10050652.

Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems Network-United States. MMWR. Morb. Mortal. Wkly Rep. 2020;69:993-8. doi: 10.15585/mmwr.mm6930e1.

Word Health Organization. Coronavirus disease (COVID-19): Epidemiological Updates and Monthly Operational Updates archive [Internet]. Geneva: WHO; 2022 [cited 2022 Dec 15]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/situation-reports-archive.

Word Health Organization. Coronavirus disease (COVID-19): Post COVID-19 condition [Internet]. Geneva: WHO; 2021 [cited 2022 Sep 22]. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition?gclid=Cj0KCQiA14WdBhD8ARIsANao07hMdHsrTk7dtGMMGNWOBus4lmsFVLD8hO8CSWIq8433jWZrOLVvsYMaAtKmEALw_wcB.

Word Health Organization. Tracking SARS-CoV-2 variants [Internet]. Geneva; WHO; 2022 [cited 2022 Nov 25]. Available from: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/.

Xia L, Chen J, Friedemann T, Yang Z, Ling Y, Liu X, et al. The course of mild and moderate COVID-19 infections-the unexpected long-lasting challenge. Open Forum Infect Dis. 2020;7:1-7. doi: 10.1093/ofid/ofaa286.

Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27(1):89-95. doi: 0.1016/j.cmi.2020.09.023.

Ziauddeen N, Gurdasani D, O'Hara ME, Hastie C, Roderick P, Yao G, et al. Characteristics and impact of Long Covid: findings from an online survey. PLoS One. 2022;17:e0264331. doi: 10.1371/journal.pone.0264331.

Downloads

Published

2024-12-31

How to Cite

1.
Belo MM de A, Lucena DCP, Santos ML dos, Pereira Cunha RJ, Pereira GHF, Freitas GRM de. Evaluation of risk factors associated with the post-COVID-19. Semin. Cienc. Biol. Saude [Internet]. 2024 Dec. 31 [cited 2026 Feb. 3];45(2):183-96. Available from: https://ojs.uel.br/revistas/uel/index.php/seminabio/article/view/50683

Issue

Vol. 45 No. 2 (2024)

Section

Artigos

License

Copyright (c) 2024 Martha Maria de Albuquerque Belo, Danielle Carmem Porto Lucena , Marília Lourencio dos Santos, Rafaela Jeane Pereira Cunha, Gabrielle Haque Fernandes Pereira, Gabriel Rodrigues Martins de Freitas

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

adopts the CC-BY-NC license for its publications, the copyright being held by the author, in cases of republication we recommend that authors indicate first publication in this journal.

This license allows you to copy and redistribute the material in any medium or format, remix, transform and develop the material, as long as it is not for commercial purposes. And due credit must be given to the creator.

The opinions expressed by the authors of the articles are their sole responsibility.
The magazine reserves the right to make normative, orthographic and grammatical changes to the originals in order to maintain the cultured standard of the language and the credibility of the vehicle. However, it will respect the writing style of the authors. Changes, corrections or suggestions of a conceptual nature will be sent to the authors when necessary.

This Journal is licensed with a license Creative Commons Assignment-NonCommercial 4.0 International.

Crossref
Scopus
Google Scholar
Europe PMC